In addition, PARP1/2 themselves are critical for Mre11-dependent replication restart at stalled replication forks, and their inhibition by PARPi also causes genome instability and synthetic lethality in HR-deficient cancer cells [42,46,47]. Here, PARP1 is linked to cancer.